NCT01765296 - Phase III Study of CG100649 in Osteoarthritis Patients | Biotech Hunter

Enrollment

362

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

April 30, 2014

Conditions

Localized Primary Osteoarthritis of HipLocalized Primary Osteoarthritis of Knee

Interventions

DRUG

CG100649

2 mg capsule

DRUG

Celecoxib

200 mg capsule

DRUG

Placebo

Mimic for CG100649 2 mg capsule and for celecoxib 200 mg capsule

Trial Locations (14)

Kyungpook National University Hospital, Daegu

Gachon University Gil Medical Center, Incheon

Inje University Seoul Paik Hospital, Seoul

Korea University Anam Hospital, Seoul

Samsung Medical Center, Seoul

Chungnam National University Hospital, Daejeon

NHIC Ilsan Hospital, Goyang-si

Seoul National University Hospital, Seoul

Hanyang University Hospital, Seoul

Gangnam Severance Hospital, Seoul

Seoul St. Mary's Hospital, Seoul

Asan Medical Center, Seoul

Boramae Medical Center, Seoul

Ewha Womans University Hospital, Seoul